Guardant Health: Cancer Detection Through Blood Sample - How the Company is Revolutionizing the Diagnostic Market
Reading Time: 3 minutes
Guardant Health is a pioneer in liquid-based cancer testing, detecting genetic tumor traces painlessly and with high precision through a simple blood sample. The FDA-approved and insurance-covered blood test Shield opens up the mass market for the company in colorectal cancer screening, which can gradually be expanded to other types of cancer. Despite ongoing investments in sales and research, rising test volumes, decreasing lab costs, and partnerships with the pharmaceutical industry pave the way for sustainable profitability. A simple...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
